The Chronicle48m
How Duke’s Office of Government Relations is approaching a second Trump term
In advance of President-elect Donald Trump’s inauguration on Monday, The Chronicle spoke with Simmons to hear his insights ...
Medindia26m
FDA approves Lilly's Omvoh® (mirikizumab-mrkz) for Crohn's disease, expanding its use to the second major type of inflammatory bowel disease
Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Omvoh® (mirikizumab-mrkz) for the treatment of moderately to severely active Crohn's ...